Additional Information
Size: |
100 µl |
Target: |
Survivin |
Conjugate: |
FITC |
Research Area: |
Neuroscience | Neurodegeneration | Cancer | Apoptosis |
Alternative Name: |
API4 Antibody, Apoptosis inhibitor 4 Antibody, Apoptosis inhibitor survivin Antibody, Baculoviral IAP repeat containing 5 Antibody, BIRC 5 Antibody, EPR 1 Antibody, IAP4 Antibody, Survivin variant 3 alpha Antibody, SVV Antibody, TIAP Antibody |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
A synthesized peptide derived from human Survivin |
Immunogen Species: |
Human |
Applications: |
WB, IHC, ICC/IF |
Host: |
Rabbit |
Isotype: |
IgG |
Species Reactivity: |
Human, Mouse, Rat |
Antibody Dilution: |
WB (1:2000), IHC (1:200), ICC/IF (1:500); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH 7.4, 50% glycerol, 150mM NaCl, 0.02% sodium azide |
Concentration: |
N/A |
Specificity: |
Detects ~16kDa, endogenous levels of total Survivin |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:1000 dilution of SPC-1335 was sufficient for detection of Survivin in 10 µg of Lung cell lysates by ECL immunoblot analysis using Goat Anti-Rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Cytoplasm, Nucleus, Chromosome |
Tissue Specificity: |
Expressed only in fetal kidney and liver, and to lesser extent, lung and brain. Abundantly expressed in adenocarcinoma (lung, pancreas, colon, breast, and prostate) and in high-grade lymphomas. Also expressed in various renal cell carcinoma cell line |
Accession Number: |
NP_001159.2 |
Gene ID: |
332 |
Swiss-Prot: |
O15392 |
Field of Use: |
For in vitro research use only. |